ImpediMed Limited (ASX:IPD) Insider Purchases A$28,800.00 in Stock

ImpediMed Limited (ASX:IPDGet Free Report) insider Andrew Grant purchased 600,000 shares of the company’s stock in a transaction on Thursday, September 5th. The shares were purchased at an average price of A$0.05 ($0.03) per share, for a total transaction of A$28,800.00 ($19,200.00).

Andrew Grant also recently made the following trade(s):

  • On Friday, August 30th, Andrew Grant acquired 1,000,000 shares of ImpediMed stock. The stock was purchased at an average price of A$0.05 ($0.03) per share, with a total value of A$50,000.00 ($33,333.33).

ImpediMed Price Performance

The company has a debt-to-equity ratio of 2.50, a quick ratio of 6.23 and a current ratio of 7.00.

About ImpediMed

(Get Free Report)

ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema, and deliver snapshot of fluid status and tissue composition; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications.

Featured Articles

Insider Buying and Selling by Quarter for ImpediMed (ASX:IPD)

Receive News & Ratings for ImpediMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImpediMed and related companies with MarketBeat.com's FREE daily email newsletter.